Town Health International Medical Group, a hospital and dentistry group from Hong Kong, is one of the few foreign entrants that is thriving in the People’s Republic of China [PRC], Healthcare Nova has been told.
Vivalto Santé intends to raise between €10-30m in capital from an equity issue that will raise the number of shareholding physicians from around 360 now to roughly 500, we've heard from multiple sources.
Five candidates have reached the final stages of consideration for entry into a medical cluster on the outskirts of Moscow, which has received US$165m of state support, we heard from its CEO and advisors.
The investment landscape in Morocco - much like the weather - has been a bit dry, despite a 2015 bill designed to open up investors outside the governmental and physician community. Healthcare Nova speaks to Mehdi Lahrichi, of McKinsey Morocco, to find out more.
A N32bn (US$82m) greenfield hospital project in the Nigerian city of Lagos consisting of a 150-bed multispecialty hospital and two primary care centres has received the backing of two investors and of potentially a third - development finance institution IFC. John Adesioye, CEO of consultancy Utopian Consulting International, says this is the sort of investment that Nigeria needs.
The award-winning New Psychiatric Hospital (GAPS) in Denmark claims to turn the waffle of patient centricity into bricks and mortar. Healthcare Europa asks Søren Daugbjerg, CEO of Vilhelm Lauritzen Architects, one of the practices behind the project, about his take on hospital design - and asks whether there is any evidence that the design of a hospital can actually improve a patient's health.
African investor Hygeia has bought the 35-bed Gold Cross Hospital in Nigeria adding to a growing network centred on the Lagoon Hospital and the country’s largest HMO. We spoke to Lagoon’s CEO, Rajeev Bhandari.
In our current environment, the Diagnostics industry is faced with increasing challenges that have an impact on how we operate (business models) and how we generate profit. Western European markets have seen caps on test volumes or decreases in reimbursement tariffs; Emerging Markets have partially enjoyed an increase in wealth but struggled in defining sustainable funding systems, many of which remain based on out-of-pocket payments.
Asklepios, Germany's second largest hospital group, has increased its holding in Rhoen, Germany's fifth largest chain - and says if the price is right, it's prepared to buy more. German medical and pharmaceutical company B. Braun has also been buying shares recently. But why?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
